Dashboard
Manage Tickers

UBX Unity Biotechnology Inc


$ 0.00 (0.36 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 605.96 $ 2.14 (0.35 %)
DIA $ 465.50 $ 0.86 (0.19 %)
SPY $ 668.42 $ 1.64 (0.25 %)
TLT $ 91.10 $ 0.14 (0.15 %)
GLD $ 386.41 $ 0.36 (0.09 %)
$ 0.0561
-- x --
-- x --
-- - --
$ 0.05 - $ 0.19
71,707
na
na
nm
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/08/2025 17:05:58

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/08/2025 12:07:32

us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says
US Stocks Likely To Open Higher: S&P 500 S...
07/02/2025 10:01:18

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 21:05:47

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/30/2025 17:06:33

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/10/2025 17:06:51

ptc-therapeutics-to-rally-around-61-here-are-10-top-analyst-forecasts-for-tuesday
PTC Therapeutics To Rally Around 61%? Here...
05/27/2025 14:04:13

this-united-states-steel-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-tuesday
This United States Steel Analyst Is No Lon...
05/27/2025 12:05:16

hc-wainwright--co-downgrades-unity-biotechnology-to-neutral-lowers-price-target-to-2
HC Wainwright & Co. Downgrades Unity Biote...
05/27/2025 10:41:24

HC Wainwright & Co. analyst Matthew Caufield downgrades Unity Biotechnology (NASDAQ:UBX) from Buy to Neutral and lowers ...

unity-biotechnology-announces-complete-36-week-results-from-phase-2b-aspire-clinical-trial-of-intravitreal-ubx1325-in-patients-with-diabetic-macular-edema
UNITY Biotechnology Announces Complete 36-...
05/05/2025 12:11:25

UBX1325 demonstrated vision gains that were comparable and statistically non-inferior to aflibercept at week 36 in a difficult-...

chardan-capital-maintains-buy-on-unity-biotechnology-maintains-4-price-target
Chardan Capital Maintains Buy on Unity Bio...
04/23/2025 12:20:55

Chardan Capital analyst Daniil Gataulin maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $4 price target.

unity-biotechnology-announces-publication-in-nejm-article-titled-safety-and-efficacy-of-senolytic-ubx1325-in-diabetic-macular-edema-evidence-highlighting-the-potential-of-senolytic-therapeutics-to-provide-long-term-improvements-in-vision-in-diabetic-macular-edema
UNITY Biotechnology Announces Publication ...
04/23/2025 12:08:00

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt or reve...

hc-wainwright--co-reiterates-buy-on-unity-biotechnology-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Unit...
04/23/2025 10:43:00

HC Wainwright & Co. analyst Matthew Caufield reiterates Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $4 pri...

chardan-capital-maintains-buy-on-unity-biotechnology-lowers-price-target-to-4
Chardan Capital Maintains Buy on Unity Bio...
03/25/2025 11:40:52

Chardan Capital analyst Daniil Gataulin maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price target fr...

hc-wainwright--co-maintains-buy-on-unity-biotechnology-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Unity...
03/25/2025 11:38:18

HC Wainwright & Co. analyst Matthew Caufield maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/24/2025 17:06:05

hc-wainwright--co-maintains-buy-on-unity-biotechnology-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Unity...
03/24/2025 15:27:21

HC Wainwright & Co. analyst Matthew Caufield maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price ...

unity-biotechnology-unveils-mixed-data-from-study-for-diabetes-related-blindness-stock-falls
Unity Biotechnology Unveils Mixed Data Fro...
03/24/2025 15:26:09

Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 2025.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/24/2025 12:10:50

unity-biotechnology-announces-topline-results-from-aspire-phase-2b-study-of-ubx1325-says-treatment-with-ubx1325-resulted-in-vision-gains-comparable-to-aflibercept-at-weeks-24-and-36-in-difficult-to-treat-patient-population
UNITY Biotechnology Announces Topline Resu...
03/24/2025 11:05:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION